Oncology · Gynecologic Oncology
The facts most likely to be tested
Squamous cell carcinoma is the most common histologic subtype of primary vaginal cancer, typically occurring in the upper third of the posterior vaginal wall.
Human papillomavirus (HPV) infection, particularly high-risk strains like HPV-16, is the primary oncogenic driver for vaginal squamous cell carcinoma.
Clear cell adenocarcinoma is the rare but classic histologic subtype associated with in utero diethylstilbestrol (DES) exposure.
Postmenopausal vaginal bleeding or a malodorous vaginal discharge are the most frequent clinical presentations in patients with vaginal malignancy.
Vaginal intraepithelial neoplasia (VAIN) is the recognized precursor lesion that often precedes the development of invasive squamous cell carcinoma.
Staging for vaginal cancer is clinical rather than surgical, utilizing physical examination, cystoscopy, and proctoscopy to determine the extent of disease.
Radiation therapy (external beam plus brachytherapy) is the primary treatment modality for the majority of invasive vaginal cancers due to the anatomical difficulty of surgical resection.
Vignette unlocked
A 68-year-old female presents to the clinic complaining of intermittent postmenopausal vaginal bleeding and a persistent foul-smelling vaginal discharge for the past three months. She has no history of hormone replacement therapy and her last Pap smear was five years ago. On physical examination, a raised, ulcerative lesion is visualized on the posterior wall of the upper third of the vagina. A biopsy of the lesion is performed.
What is the most likely histologic diagnosis?
Squamous cell carcinoma
The patient's presentation of postmenopausal bleeding and a lesion on the upper posterior vaginal wall is classic for squamous cell carcinoma, the most common primary vaginal malignancy.
Full handout
High yield triage
Etiology / Epidemiology
Rare malignancy primarily associated with HPV infection and prior cervical cancer.
Clinical Manifestations
Presents as postmenopausal vaginal bleeding or postcoital spotting.
Diagnosis
Biopsy is the gold standard; staging is clinical via pelvic exam under anesthesia.
Treatment
Radiation therapy is the primary treatment for most stages; surgery for limited disease.
Prognosis
Overall 5-year survival is ~50%, heavily dependent on stage at diagnosis.
Full handout
Epidemiology & Etiology
Primary vaginal cancer is rare, accounting for <2% of gynecologic malignancies. The most significant risk factor is high-risk HPV (types 16/18). Patients with a history of cervical intraepithelial neoplasia or prior hysterectomy for cervical cancer remain at elevated risk.
Pertinent Anatomy
The posterior wall of the upper third of the vagina is the most common site for squamous cell carcinoma. Lymphatic drainage follows the cervical pattern, with upper lesions draining to the pelvic lymph nodes and lower lesions to the inguinal nodes.
Pathophysiology
Most cases are squamous cell carcinoma arising from chronic HPV-induced dysplasia. Adenocarcinoma is rare, historically linked to in utero diethylstilbestrol (DES) exposure. Progression occurs via direct local invasion into the bladder or rectum or through lymphatic spread.
Clinical Manifestations
Patients often present with painless vaginal bleeding or a malodorous discharge. Physical exam may reveal a fungating mass or ulceration. Red flags include pelvic pain, hematuria, or rectal bleeding, which suggest advanced local invasion.
Diagnosis
Diagnosis requires a biopsy of the suspicious lesion. Staging is performed clinically using pelvic exam under anesthesia (EUA), cystoscopy, and proctoscopy to assess local extension. MRI or PET/CT is used to evaluate for lymph node involvement and distant metastasis.
Treatment
Radiation therapy (external beam plus brachytherapy) is the standard of care for most stages. Surgical resection is reserved for small, localized lesions in the upper vagina. Contraindications to surgery include advanced stage or involvement of the bladder/rectum.
Prognosis
Prognosis is poor for advanced stages due to proximity to pelvic organs. Recurrence is common, requiring lifelong surveillance with cytology and imaging. 5-year survival drops significantly if pelvic lymph nodes are positive.
Differential Diagnosis
Cervical cancer: usually involves the cervix primarily
Vaginal atrophy: common in postmenopausal women, lacks a discrete mass
Vaginal polyps: typically benign, pedunculated growths
Condyloma acuminata: warty lesions, usually multiple
Metastatic disease: most common vaginal malignancy is secondary from endometrial or cervical primary